共 50 条
[21]
Efficacy and safety of lenvatinib versus sorafenib in first-line treatment of advanced hepatocellular carcinoma: A meta-analysis
[J].
FRONTIERS IN ONCOLOGY,
2022, 12
[22]
The efficacy and safety of chemotherapy with or without anti-PD-1 for the first-line treatment of advanced urothelial carcinoma
[J].
CANCER MEDICINE,
2023, 12 (23)
:21129-21137
[27]
Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first-line treatment for unresectable hepatocellular carcinoma
[J].
CANCER MEDICINE,
2023, 12 (06)
:7077-7089
[29]
Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysis
[J].
CANCER PATHOGENESIS AND THERAPY,
2024, 2 (02)
:81-90